✦ LIBER ✦

Activated protein C and pulmonary embolism

✍ Scribed by Ian Roberts; Zahir Amoura; Thomas Papo; Jean-Charles Piette; H. Bounameaux; S. Desmarais; G. Reber; A. Perrier; P. de Moerloose; M. Bazzan; E. Aluffi; A. Vaccarino; P. Schinco; B. Montaruli

Book ID: 118562112
Publisher: The Lancet
Year: 1996
Tongue: English
Weight: 357 KB
Volume: 347
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(96)91666-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Resistance to activated protein C in an

Resistance to activated protein C in an unselected population of patients with pulmonary embolism

✍ S. Desmarais; P. de Moerloose; G. Reber; P. Minazio; H. Bounameaux; A. Perrier 📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 247 KB

Pulmonary and Paradoxical Embolism in Pr

Pulmonary and Paradoxical Embolism in Protein C and S Deficient Patient

✍ Sanjay Kumar; Irfan Khan; Richard Milton; Ayyaz A. Ali; David J. O’Regan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Triggering activities of acute pulmonary

Triggering activities of acute pulmonary embolism and paradoxical embolism

✍ Tsung O. Cheng 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Anaesthesia and pulmonary embolism

✍ Leonard C. Jenkins; Horace B. Graves 📂 Article 📅 1961 🏛 Springer-Verlag 🌐 French ⚖ 828 KB

Pulmonary embolism

✍ Daniel A. Evans 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 18 KB

Tissue plasminogen activator and acute p

Tissue plasminogen activator and acute pulmonary embolism

✍ Samuel Z. Goldhaber; Craig M. Kessler; John Heit; John E. Markis; G. V. R. K. Sh 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

We assessed the efficacy and safety of peripheral intravenous recombinant human tissue-type plasminogen activator (rt-PA) in 47 patients with angiographically documented pulmonary embolism (PE). We administered 50 mg/2 h and, if necessary, an additional 40 mg/4 h. By 6 hours, 94% of the patients had